These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 29619024)
1. Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene. Casucci M; Falcone L; Camisa B; Norelli M; Porcellini S; Stornaiuolo A; Ciceri F; Traversari C; Bordignon C; Bonini C; Bondanza A Front Immunol; 2018; 9():507. PubMed ID: 29619024 [TBL] [Abstract][Full Text] [Related]
2. CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice. Porcellini S; Asperti C; Corna S; Cicoria E; Valtolina V; Stornaiuolo A; Valentinis B; Bordignon C; Traversari C Front Immunol; 2020; 11():99. PubMed ID: 32117253 [TBL] [Abstract][Full Text] [Related]
3. Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer. Stornaiuolo A; Valentinis B; Sirini C; Scavullo C; Asperti C; Zhou D; Martinez De La Torre Y; Corna S; Casucci M; Porcellini S; Traversari C Hum Gene Ther; 2021 Jul; 32(13-14):744-760. PubMed ID: 33554732 [TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma. Sommer C; Boldajipour B; Kuo TC; Bentley T; Sutton J; Chen A; Geng T; Dong H; Galetto R; Valton J; Pertel T; Juillerat A; Gariboldi A; Pascua E; Brown C; Chin SM; Sai T; Ni Y; Duchateau P; Smith J; Rajpal A; Van Blarcom T; Chaparro-Riggers J; Sasu BJ Mol Ther; 2019 Jun; 27(6):1126-1138. PubMed ID: 31005597 [TBL] [Abstract][Full Text] [Related]
5. Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells. Friedman KM; Garrett TE; Evans JW; Horton HM; Latimer HJ; Seidel SL; Horvath CJ; Morgan RA Hum Gene Ther; 2018 May; 29(5):585-601. PubMed ID: 29641319 [TBL] [Abstract][Full Text] [Related]
6. Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7. Amatya C; Pegues MA; Lam N; Vanasse D; Geldres C; Choi S; Hewitt SM; Feldman SA; Kochenderfer JN Mol Ther; 2021 Feb; 29(2):702-717. PubMed ID: 33129371 [TBL] [Abstract][Full Text] [Related]
7. Gene Modification and Immunological Analyses for the Development of Immunotherapy Utilizing T Cells Redirected with Antigen-Specific Receptors. Ochi T; Maruta M; Hirano N Methods Mol Biol; 2019; 2048():27-39. PubMed ID: 31396926 [TBL] [Abstract][Full Text] [Related]
8. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Casucci M; Nicolis di Robilant B; Falcone L; Camisa B; Norelli M; Genovese P; Gentner B; Gullotta F; Ponzoni M; Bernardi M; Marcatti M; Saudemont A; Bordignon C; Savoldo B; Ciceri F; Naldini L; Dotti G; Bonini C; Bondanza A Blood; 2013 Nov; 122(20):3461-72. PubMed ID: 24016461 [TBL] [Abstract][Full Text] [Related]
9. CD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype. Li S; Tao Z; Xu Y; Liu J; An N; Wang Y; Xing H; Tian Z; Tang K; Liao X; Rao Q; Wang M; Wang J Hum Gene Ther; 2018 May; 29(5):626-639. PubMed ID: 29409351 [TBL] [Abstract][Full Text] [Related]
10. Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line. Kang CH; Kim Y; Lee HK; Lee SM; Jeong HG; Choi SU; Park CH Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271901 [TBL] [Abstract][Full Text] [Related]
11. A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes. Schäfer D; Henze J; Pfeifer R; Schleicher A; Brauner J; Mockel-Tenbrinck N; Barth C; Gudert D; Al Rawashdeh W; Johnston ICD; Hardt O Front Immunol; 2020; 11():1704. PubMed ID: 32849600 [TBL] [Abstract][Full Text] [Related]
13. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy. Zhang Z; Jiang J; Wu X; Zhang M; Luo D; Zhang R; Li S; He Y; Bian H; Chen Z Front Med; 2019 Feb; 13(1):57-68. PubMed ID: 30721445 [TBL] [Abstract][Full Text] [Related]